ExodusPoint Capital Management »

Galectin Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $343k 83k 4.16
2024-09-30 $81k 30k 2.74
2021-06-30 $135k 42k 3.21
2019-03-31 $362k 71k 5.11
2018-12-31 $119k 35k 3.44

More positions owned by ExodusPoint Capital Management

NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom Put Option (AVGO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp Call Option (MDY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Wal-Mart Stores (WMT)
Tesla Motors Put Option (TSLA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Meta Platforms Cl A Call Option (META)
Electronic Arts (EA)
Evergy (EVRG)
Boeing Company (BA)

View all positions for ExodusPoint Capital Management

Top funds holding Galectin Therapeutics

Vanguard Group
Advisor Group Holdings
Susquehanna International
BlackRock
Marshall Wace
Sontag Advisory
Geode Capital Management
Jane Street
Commonwealth Equity Services
LPL Financial
Goldman Sachs Group
Geneos Wealth Management
State Street Corporation
Sovran Advisors
Vivaldi Capital Management

View all funds holding Galectin Therapeutics